1) montelukast
孟鲁司特钠
1.
Clinical Study on early intervention of infant asthma With montelukast;
孟鲁司特钠对婴幼儿哮喘的早期干预作用
2.
Effects of Montelukast on lung function in preschool children with asthma;
孟鲁司特钠对哮喘儿童肺功能的影响
3.
Pharmacokinetics and relative bioavailability of montelukast film-coated tablets and chewable tablets;
孟鲁司特钠药动学及其国产片剂/咀嚼片剂人体相对生物利用度研究
2) montelukast sodium
孟鲁司特钠
1.
Effect of montelukast sodium on adhesion molecule in the acute exacerbation period of chronic obstructive pulmonary disease;
孟鲁司特钠对慢性阻塞性肺疾病急性加重期黏附因子的影响
2.
Study of montelukast sodium and mycobacterium phlei F.U.36 on asthma infant;
孟鲁司特钠和草分枝杆菌F.U.36治疗婴幼儿哮喘的研究
3.
Protective effect of montelukast sodium on isoproterenol-induced myocardial necrosis in rats;
孟鲁司特钠对大鼠异丙肾上腺素心肌坏死的保护作用
3) Montelukast
孟鲁司特
1.
Clinical efficacy of montelukast associated with seratrodast on asthma patients;
塞曲司特联合孟鲁司特治疗支气管哮喘疗效观察
2.
Observation of Curative Effect of combing Montelukast with Inhaled corticosteroids in treatment of Children with CVA;
孟鲁司特联合吸入型糖皮质激素治疗儿童咳嗽变异性哮喘的疗效观察
3.
Effect of montelukast and dexamethasone on inflammation of asthma;
孟鲁司特和地塞米松对哮喘炎症的作用
4) montelukast sodium chewable tablets
孟鲁司特钠咀嚼片
1.
Enuresis induced by montelukast sodium chewable tablets in a child;
患儿遗尿与孟鲁司特钠咀嚼片有关
5) montelukast sodium (singulair)
孟鲁斯特钠(顺尔宁)
1.
Objective To explore the effects of combining salmeterol/fluticasone propionate (seretide) and montelukast sodium (singulair) on patients with COPD by analyzing lung function.
目的探讨沙美特罗替卡松(舒利迭)联合孟鲁斯特钠(顺尔宁)对慢性阻塞性肺疾病(COPD)患者肺功能的影响。
6) montelukast
孟鲁斯特
1.
Effects of Montelukast on Expression of IL -SmRNA and IL -5 Protein in Asthmatic Model;
孟鲁斯特对哮喘模型IL-5mRNA和IL-5蛋白表达的影响
2.
Objective To investigate the effects of montelukast(MK),a selective cysteinyl leukotriene receptor 1 antagonist on interleukin(IL)-5 and eotaxin expression as well as serum total immunoglobulin E(IgE) production during MK treatment of mouse acute asthma airway inflammation.
目的应用白三烯受体1拮抗剂孟鲁斯特(montelukast,MK)治疗小鼠急性哮喘呼吸道炎症,探讨MK对白细胞介素-5(IL-5)和嗜酸性粒细胞趋化因子(eotaxin)表达及血清总IgE水平的影响。
3.
A: normal control group, B: asthma model group, C: dexamethasone group, D: montelukast group.
方法:本实验分两部分组成,第一部分:将24只SD大鼠随机分成4组:A(正常对照组)、B(哮喘模型组)、C(地塞米松组)和D(孟鲁斯特组)。
补充资料：孟鲁司特钠
分子式：C35H35ClNNaO3S
分子量：608.17
CAS号：151767-02-1
性质：
分子量：608.17
CAS号：151767-02-1
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条